Opendata, web and dolomites


Defining the role of lysosomal trafficking in age-associated anabolic resistance in human skeletal muscle

Total Cost €


EC-Contrib. €






Project "LYSOTRACK" data sheet

The following table provides information about the project.


Organization address
address: Edgbaston
postcode: B15 2TT

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website
 Total cost 195˙454 €
 EC max contribution 195˙454 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2015
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2016
 Duration (year-month-day) from 2016-09-01   to  2018-08-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

The reduced ability of skeletal muscle to grow, termed anabolic resistance (AR), is thought to be a major cause of age-associated muscle loss (sarcopenia). At the cellular level, AR is caused by an impaired activation of the protein kinase mTORC1, which in turn blunts protein synthetic responses to anabolic stimuli. Lysosomal trafficking is critical for the full activation of mTORC1, with the blocking of this event creating anabolic resistance in otherwise healthy cells. However, to date, this phenomenon has not been examined in human skeletal muscle. Therefore, our working hypothesis is that alterations in lysosomal trafficking may be an underlying mechanism to explain impaired mTORC1 activity and AR in elderly individuals. To address this hypothesis, we will define, for the first time, the role and regulation of lysosomal trafficking in age-associated AR in human skeletal muscle.

Through a combination of in-vitro and in vivo studies we will examine (1) whether genetic induction of lysosomal trafficking can activate mTORC1 and overcome chemical/nutrient induced AR in human primary myotubes, (2) whether genetic knockdown of proteins that stimulate lysosomal trafficking can inhibit mTORC1 activity and cause AR, and (3) examine whether lysosomal trafficking differs between young and elderly subjects, in vivo, in response to anabolic stimuli such as amino acids and resistance exercise.

The importance of this work should not be understated, given that the number of individuals aged over 60 and 80 years is expected to triple and quadruple respectively by 2050. By advancing the understanding of why elderly individuals exhibit AR and how this phenomenon may contribute to the development of sarcopenia, the work proposed herein has great potential for the development of novel therapeutic approaches to prevent or reduce the occurrence of AR, reduce the severity of sarcopenia which in turn will dramatically improve quality of life.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LYSOTRACK" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LYSOTRACK" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

BiMetaCat (2019)

Two Are Better Than One: Bimetallic Catalysts for the Conversion of Lignin-Derived Aryl-Ethers

Read More  


The missing pillar. European social policy and Eurosceptic challenges (SOCIALEU)

Read More  

InProSMod (2021)

Cholinergic and NMDAR-dependent recruitment of Layer 1 Interneuron shapes cortical motor Processing through network States Modulation

Read More